Skip to main content

more options


Joseph E. Wedekind*1, Richard Gillilan2, Alena Janda1, Jolanta Krucinska1, Jason D. Salter1, Ryan P. Bennett1, Jay Raina3, and Harold C. Smith1
1Department of Biochemistry & Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642
2Macromolecular Structure Facility at the Cornell High Energy Synchrotron Source (MacCHESS), Cornell University, Ithaca, NY 14853
3Immunodiagnostics Inc., Woburn, MA 01801

*correspondence to: joseph.wedekind@rochester.edu
 

Abstract:
Human APOBEC3G (hA3G) is an innate deoxycytidine-to-deoxyuridine deaminase that restricts HIV-1 infectivity by introducing catastrophic mutations into the viral genome in the absence of the HIV-1 factor vif.  hA3G from HIV-permissive, activated CD4+ T-cells exists as an inactive, high-molecular-mass (HMM) complex that can be transformed in vitro into an enzymatically active, low-molecular-mass (LMM) variant comparable to that identified in HIV-non-permissive CD4+ T-cells.  Similarly, hA3G has been detected in viral capsids as an inactivated ribonucleoprotein whose activity restoration depends upon the RNase H function of reverse transcriptase.  Collectively, these data support a model that suggests inactivation of hA3G depends on RNA. To elucidate how RNA influences the structural organization of hA3G, we determined low resolution structures of recombinantly expressed HMM- and LMM-variants by small angle X-ray scattering. The results indicated that LMM particles have an extended shape, dissimilar to known cytidine deaminase crystal structures.  Structure-based biochemical experiments corroborated these observations and suggested that each LMM particle comprises a tail-to-tail dimer of identical subunits.  Additional studies indicated that recombinant LMM-hA3G binds with avidity to nucleic acids and that this interaction blocks hA3G deamination.  Shape analysis of LMM- and HMM-particles led us to propose a hierarchical assembly model whereby symmetric association of LMM dimers produces inactive HMM aggregates.  These observations imply that the disruption of cellular HMM species will require regulation of protein-RNA, as well as protein-protein interactions, which has implications for therapeutic development.

abstract (pdf)

2008 Run

Nov 19th - Dec 22nd